Immunai is thrilled to announce a monumental funding round, securing an impressive $300 million to further its mission of revolutionizing the landscape of immunology through cutting-edge single-cell biology and artificial intelligence. With this substantial investment, Immunai aims to comprehensively map and reprogram the immune system, an endeavor that promises to power groundbreaking therapeutic discoveries and enhance the drug development pipeline. The ability to harness the insights gleaned from the immune system at the single-cell level holds the key to unlocking new treatments for a myriad of diseases, ultimately improving patient outcomes across the globe. This funding will not only accelerate Immunai’s ongoing projects but will also empower the company to expand its research capabilities and recruit top-tier talent in the fields of immunology and AI. As Immunai continues to push the boundaries of what is possible in understanding and manipulating the immune system, this support underscores the growing recognition of the transformative potential of combining cutting-edge technology with biological research. The team is energized by the confidence placed in its vision and is poised to make significant strides in the development of innovative therapies that address some of the most pressing challenges in medicine today. With this funding, Immunai is set to pave the way for a new era of therapeutic discovery, where AI and single-cell insights converge to create personalized, effective treatments that can change lives for the better.
Immunai Secures $300 Million in Funding to Revolutionize Immune System Mapping and Therapeutic Development with AI
Get the full Immunai company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Tensormesh
Tensormesh is an AI inference optimization company that never charges you twice for cached tokens, making AI applications faster and dramatically cheaper to run anywhere. Created on leading open-source frameworks, AI teams building agents and LLM applications deploy in minutes with full observability and granular workload control.
$20.0M Unknown
today
Navigate AI
We advise businesses to bring acceleration on their AI journey
$25.0M Seed
today
Cypher AI
Enable scientists to create custom software tools on demand with advanced scientific aware AI agent. Instead of endless manual data wrangling or rigid, off-the-shelf software, scientists use Cypher’s AI agent to instantly create and run custom software tools, all without requiring coding skills. Researchers can now process, analyze, and manage data at unprecedented speed, unlocking more time for real discovery and innovation.
$2.0M Seed
today
Sorce
Applying to jobs should be easier and we're making it a reality
$500.0K Seed
today
hi finance
Hi Finance helps students and grads take control of their money, from grant applications to full financial planning. We’re a team of planners, builders, and advisors creating a new model of financial services: • Flat-fee advice with no product sales or hidden commissions • A clear path from campus to long-term financial success • Real human advisors backed by smart tools and systems We’re building the next generation of CFPs focused on being client-first. If you’re excited by transparent advice, smarter financial systems, and helping thousands of Canadians get ahead, we’re hiring!
$500.0K Pre-seed
today